D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Walt Disney
DIS
|
+$410M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$386M |
| 4 |
GE Aerospace
GE
|
+$196M |
| 5 |
Dell
DELL
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$374M |
| 2 |
PayPal
PYPL
|
+$289M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$278M |
| 4 |
Nike
NKE
|
+$227M |
| 5 |
Amgen
AMGN
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.11% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEN
751
DELISTED
ZENDESK INC
ZEN
| $12.7M | 0.02% |
412,129
+243,684
| +145% | +$7.24M |
|
|
POT
752
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $12.7M | 0.02% |
775,200
-9,100
| -1% | -$150K |
|
753
Simon Property Group
SPG
$74.5B
| $12.6M | 0.02% |
60,916
+2,885
| +5% | +$626K |
|
754
CALL
CVS Health
CVS
$137B
| $12.6M | 0.02% |
141,400
+22,100
| +19% | +$2.09M |
|
|
FLOW
755
DELISTED
SPX FLOW, Inc.
FLOW
| $12.6M | 0.02% |
406,658
-3,079
| -0.8% | -$85.9K |
|
756
CALL
Northrop Grumman
NOC
$77B
| $12.6M | 0.02% |
58,700
| – | – |
|
757
Nice
NICE
$5.29B
| $12.5M | 0.02% |
186,839
-75,131
| -29% | -$5M |
|
758
PUT
NOV
NOV
$7.45B
| $12.5M | 0.02% |
340,000
| – | – |
|
|
STOR
759
DELISTED
STORE Capital Corporation
STOR
| $12.5M | 0.02% |
423,404
-513,023
| -55% | -$15.3M |
|
|
IOC
760
DELISTED
Interoil Corporation
IOC
| $12.5M | 0.02% |
245,028
+95,317
| +64% | +$4.67M |
|
|
GWPH
761
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $12.5M | 0.02% |
93,900
+26,200
| +39% | +$2.5M |
|
762
SITE Centers
SITC
$230M
| $12.4M | 0.02% |
553,394
-79,336
| -13% | -$1.91M |
|
763
PUT
First Solar
FSLR
$21.8B
| $12.4M | 0.02% |
314,200
+227,200
| +261% | +$9.41M |
|
764
CALL
Kimberly-Clark
KMB
$36.4B
| $12.4M | 0.02% |
98,300
+16,400
| +20% | +$2.12M |
|
765
PUT
AbbVie
ABBV
$458B
| $12.4M | 0.02% |
196,100
+106,100
| +118% | +$6.87M |
|
|
TWOU
766
DELISTED
2U Inc
TWOU
| $12.4M | 0.02% |
10,756
+6,403
| +147% | +$6.68M |
|
|
PGRE
767
DELISTED
Paramount Group
PGRE
| $12.3M | 0.02% |
752,023
+313,768
| +72% | +$5.39M |
|
768
CALL
Cencora
COR
$60.3B
| $12.3M | 0.02% |
152,400
+46,700
| +44% | +$4M |
|
769
Brady Corp
BRC
$4.45B
| $12.3M | 0.02% |
355,682
+6,279
| +2% | +$207K |
|
770
CALL
Intercontinental Exchange
ICE
$82.4B
| $12.3M | 0.02% |
+228,500
| New | +$12.5M |
|
|
WAGE
771
DELISTED
WageWorks, Inc.
WAGE
| $12.2M | 0.02% |
200,809
+40,539
| +25% | +$2.48M |
|
|
JNS
772
DELISTED
Janus Capital Group Inc
JNS
| $12.2M | 0.02% |
867,314
-155,590
| -15% | -$2.25M |
|
773
DTE Energy
DTE
$31.1B
| $12.1M | 0.02% |
152,311
-65,704
| -30% | -$5.35M |
|
774
W.W. Grainger
GWW
$65.3B
| $12.1M | 0.02% |
53,683
-9,181
| -15% | -$2.06M |
|
775
Lexicon Pharmaceuticals
LXRX
$1.02B
| $12.1M | 0.02% |
667,130
+469,827
| +238% | +$7.56M |
|
Similar funds
D.E. Shaw & Co's Q3 2016 Portfolio in Review
As of Q3 2016, D.E. Shaw & Co held 3,773 positions worth $56.7B, up 4.5% from $54.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q3 2016 filing shows 448 new, 1,212 increased, 1,374 reduced and 429 closed positions. Its largest new stake was Dell: 13,808,231 shares worth $185M. The largest sale was Meta Platforms (Facebook), an estimated $374M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 11% a quarter earlier, followed by Technology and Financials.
- D.E. Shaw & Co's largest Q3 2016 buy was Dell: 13,808,231 shares worth $185M.
- D.E. Shaw & Co added most to Apple in Q3 2016, an estimated $453M increase.
- D.E. Shaw & Co's biggest Q3 2016 reduction was Meta Platforms (Facebook), cutting an estimated $374M.
- D.E. Shaw & Co fully exited EMC CORPORATION in Q3 2016, selling an estimated $278M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $56.7B portfolio in Q3 2016.
- D.E. Shaw & Co opened 448 new positions and closed 429 in Q3 2016.
- D.E. Shaw & Co's portfolio value rose 4.5% quarter-over-quarter to $56.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2016, filed 14 Nov 2016.